Dengue is the most prevalent arthropod-borne viral disease affecting humans, with 24 severe dengue typified by potentially fatal microvascular leakage and hypovolaemic shock.
INTRODUCTION

70
Dengue virus (DENV) is a serocomplex of four viruses (DENV-1-4) and the most 71 prevalent arthropod-borne virus (arbovirus) affecting humans. Almost half the world's 72 population lives in at-risk areas across the tropics and subtropics, with an estimated 390 73 million infections and 96 million symptomatic cases per year (1). Dengue patients experience 74 a range of symptoms including high fever, leucopoenia, maculopapular rash, retro-orbital pain, 75 arthralgia and myalgia (2, 3) . A minority of patients (approximately 500,000 cases per year) 76 develop severe dengue, typified by cardiovascular complications such as plasma leakage 77 (e.g. pleural effusion, oedema) and/or bleeding (haemorrhage) manifesting during 78 defervescence that can lead to hypovolaemic shock, organ failure and death (2, 3). Fluid 79 replacement therapy and other supportive treatments reduce the death rate, but there are no 80 specific drugs to treat dengue and no diagnostic measure to predict the development of the 81 life-threatening severe dengue (2-4).
82
At a microvascular level, the precise mechanisms leading to vascular leakage in 83 severe dengue remain incompletely understood. A dysregulated cytokine response has been 84 proposed to be a major contributor to vascular hyperpermeability, especially in heterotypic 85 secondary infections with a different DENV serotype to the first infection (3, 5, 6) . Antibodies 86 against the viral non-structural protein NS1 have also been shown to bind to endothelial cells 87 in secondary infections, causing their apoptosis (7-9). In addition, NS1 protein is abundantly 88 secreted into patient serum and has been shown to directly induce endothelial cell 89 hyperpermeability (10, 11) . Serum NS1 concentrations in dengue patients vary widely.
90
Although concentrations as high as 15,000 ng/ml have been recorded in some patients, 91 concentrations of 10-1,000 ng/ml are more typical, with one study suggesting that levels above 92 600 ng/ml may be predictive of severe disease (12) (13) (14) . NS1 enters endothelial cells through 93 dynamin-and clathrin-dependent endocytosis and induces the expression of secreted cellular 94 sialidases, heparanase and cathepsin L that cleave components of the endothelial cell 95 glycocalyx reducing the integrity of the barrier (15-18). Inhibitors of sialidases and 96 5 heparanases reduce NS1-dependent endothelial hyperpermeability in vitro, and NS1 97 vaccination has been shown to protect against vascular leakage in vivo (11, 17) .
98
The published mechanistic studies into NS1-induced dengue vascular leakage 99 primarily assessed endothelial cell function. However, the vessels affected in severe dengue 100 in vivo, primarily capillaries and post-capillary venules, are comprised of an endothelial cell 101 lining surrounded by perivascular cells (pericytes) embedded within the basement membrane 102 ( Fig 1A) (19, 20) . There is a dynamic relationship between pericytes and endothelial cells, with 103 two-way paracrine signalling as well as contact-mediated communication facilitated by 104 pericyte pseudopod extensions that wrap around the endothelial cells (21). Pericytes are 105 essential in both blood vessel formation to drive endothelial cell migration, proliferation and 106 maturation, and in homeostasis for the maintenance and regulation of the endothelial barrier 107 in established vessels (22, 23) . Pericyte deficiency is perinatally lethal in mouse models due 108 to widespread vascular leakage and aneurysms (24). In established vessels, pericyte 109 dysfunction leads to microvascular hyperpermeability, such as in diabetic retinopathy where 110 chronic exposure to heightened glucose levels due to unmanaged diabetes causes capillary 111 occlusions, microaneurysms and blindness (25). To date, the role of pericytes in the aetiology 112 of vascular hyperpermeability caused by an infectious disease has not been described.
113
Here, we use microvascular hyperpermeability induced by DENV NS1 as a model to 114 demonstrate a crucial role for pericytes in amplifying an infectious haemorrhagic syndrome.
115
We show that DENV-2 NS1 induces hyperpermeability in in vitro co-cultures of primary 116 pericytes and primary endothelial cells, and that the observed hyperpermeability is greater 117 than for endothelial cells cultured alone. NS1 does not broadly affect all pericyte functions, but 118 rather specifically reduces the capacity of pericytes to support endothelial cell function in 3D 119 microvascular models. Finally, we demonstrate that NS1-induced hyperpermeability is not 120 dependent on endothelial-pericyte cell contact and is at least partially mediated through effects 121 on paracrine signalling. Importantly, the inclusion of pericytes in our in vitro model of dengue 122 microvascular hyperpermeability reveals effects at markedly lower NS1 concentrations than 123 6 in previously published studies, more representative of serum NS1 levels commonly observed 124 in patients with severe dengue. Our findings could inform new strategies for developing 125 diagnostics and treatments for severe dengue, and could have wide-reaching implications for 126 the role of pericytes in other infectious vascular leakage syndromes. Fig 1C) . Treatment of these endothelial-pericyte co-cultures with 500 ng/ml DENV-148 2 NS1 significantly reduced endothelial barrier function ( Fig 1C) . This effect was evident from 149 7 8 h post-treatment and by 16 h the TEER of the co-cultures was indistinguishable from that of 150 endothelial cells cultured alone. This indicates that NS1 completely abolished the ability of 151 pericytes to support the barrier function of endothelial cells in this system. In contrast, 152 ovalbumin did not affect permeability of the co-culture ( Fig 1D) , confirming the specificity of 153 the observed pericyte dysfunction induced by DENV-2 NS1.
154
Notably, the absolute magnitude of the TEER decrease was significantly higher in the 155 co-cultures compared to endothelial cells cultured alone, indicating a stronger effect of NS1 156 on permeability in the presence of pericytes (Fig 1Ei) . Even when we accounted for the higher 157 absolute TEER of the endothelial-pericyte co-cultures by normalising to the respective 158 untreated controls, the decrease in barrier function in the co-culture was almost double that of 159 endothelial cell monocultures at 20 h and 24 h post-treatment (Fig 1Eii) .
160
Taken together, these results indicate that DENV-2 NS1 induces extensive dysfunction 161 in primary human pericytes, leading to their inability to support endothelial cell barrier function.
162
Furthermore, the effect NS1 has on permeability is more pronounced in the presence of pericytes to support endothelial cell and capillary functionality (26). In our hands, endothelial 174 cells cultured on Matrigel formed abundant capillary-like structures after 6 h and the presence 8 of pericytes visibly increased the thickness of the branches of these structures (Fig 2A) . This 176 increase in branch width is due to the physical association of pericytes with the endothelial 177 structures, and the secretion of pro-angiogenic factors by pericytes directly stimulating the 178 endothelium (26).
179
Treatment of 3D endothelial-pericyte co-cultures with 500 ng/ml DENV-2 NS1 caused 180 a reduction in branch width (Fig 2A) , indicating a dysfunctional interaction between endothelial 181 cells and pericytes. Quantification of NS1's effect revealed a dose-dependent decrease in 182 branch width, with doses above 300 ng/ml completely abolishing the contribution of pericytes 183 to capillary-like structure formation (Fig 2Bi) . In contrast, treatment with ovalbumin ("ova") did 184 not affect the endothelial-pericyte interaction in Matrigel (Fig 2Bii) , demonstrating the 185 specificity of the NS1 effect. Furthermore, branch width was not impacted by NS1 treatment 186 when endothelial cells were cultured in the absence of pericytes, indicating that NS1 187 specifically interferes with the ability of pericytes to support the endothelium rather than the 188 intrinsic angiogenic capacity of endothelial cells (Fig 2Biii) . Taken together, our data suggest 189 that the amplified effect NS1 has on endothelial permeability in the presence of pericytes is 
195
two defining roles of pericytes. In order to exclude that the observed effect is due to a reduced 196 viability of the pericyte or the endothelial populations, we treated each cell type separately 197 with a range of NS1 concentrations (50-500 ng/ml). NS1 treatment for 48h did not affect cell 198 growth or viability in either endothelial cells or pericytes ( Fig 3A) .
199
In order to support the microvascular architecture, pericytes must be able to migrate 200 along capillaries. For this reason, we tested the intrinsic migratory capacity of pericytes upon 201 9 treatment with NS1. DENV-2 NS1 concentration as high as 1,000 ng/ml had no effect on 202 pericyte migration compared to the untreated control in a scratch assay measuring 'wound' 203 closure following manual disruption of the cell monolayer ( Fig 3B) . These data further support 204 our finding that NS1 specifically affects the endothelial-pericyte interaction.
205
NS1 impacts pericyte paracrine signalling that supports the endothelial barrier 206 Pericytes regulate endothelial permeability through cell-cell interactions and paracrine 207 signalling (22). In order to assess the paracrine contribution of pericytes to endothelial barrier 208 function, we modified our TEER assay by seeding pericytes on the bottom of the well instead 209 of on the membrane. This prevents any contact between endothelial cells and pericytes across 210 the porous membrane. In this non-contact TEER, co-culture of endothelial cells with pericytes 211 increased endothelial barrier function to a similar extent to that observed in semi-contact 212 TEER (Fig 4A, compared to Fig 1C) . This confirms that pericytes' contribute to the capillary 213 barrier is not simply as an additional physical layer, but as a master regulator of endothelial 214 permeability. Treatment with 500 ng/ml DENV-2 NS1 decreased the resistance of the 215 endothelial cell monolayer in the non-contact co-culture starting at 8 h post-treatment, and 216 from 12 h post-treatment the contribution of pericytes to endothelial barrier function was 217 completely ablated ( Fig 4A) . Furthermore, neither the absolute nor the relative effect size of 218 NS1 treatment was significantly different when comparing the contact and non-contact co-219 cultures ( Fig 4B) , indicating that the effect of NS1 is mediated at least in part through paracrine 220 modulators of endothelial barrier function. 226 had no effect on pericyte viability or migration, suggesting that NS1 specifically reduces the 227 10 capacity of pericytes to support endothelial cell functions required for microvascular barrier 228 formation and maintenance. We furthermore demonstrated that the effects of NS1 are at least 229 partially the result of altered paracrine signalling between pericytes and endothelial cells.
230
Since pericytes are an essential component of the microvascular architecture, we propose 231 that pericytes play a crucial role in the aetiology of severe dengue. Interestingly, the distantly 232 related flavivirus Japanese encephalitis virus (JEV) was recently shown to infect pericytes in 233 the blood-brain barrier, where pericytes are also fundamental in maintaining the integrity of 234 the barrier, allowing the virus to gain access to the brain to cause encephalitis (28). Pericytes 235 may therefore play a wider role in the pathogenesis of flaviviruses that lead to diverse 236 symptomatic outcomes.
237
Our data strongly suggest that NS1 interferes with the dynamic crosstalk between 238 endothelial cells and pericytes. The specific factors mediating the NS1-dependent 239 hyperpermeability remain unknown. Among several vasoactive molecules reported to be 240 overrepresented in dengue patients, vascular endothelial growth factor (VEGF) has been 241 shown to be upregulated twenty-fold compared to healthy controls (6). VEGF is abundantly 242 (but not exclusively) secreted by pericytes to control endothelial cell angiogenesis and 243 negatively regulates pericyte function (29, 30) . Platelet-derived growth factor BB (PDGF-BB), 244 a critical regulator of pericyte association with the endothelium, was also upregulated 20-60-245 fold in dengue patients, with a further increase at defervescence in patients with severe 246 dengue (31). This timing coincides with the development of severe symptoms and is 247 suggestive of an endothelial response to pericyte dysfunction. Finally, low levels of 248 angiopoietin 1 (Ang1) and elevated levels of its antagonist angiopoietin 2 (Ang2) have been 249 associated with dengue vascular leakage (5, 32), and the Ang1:Ang2 ratio has been proposed 250 as a diagnostic marker for patients at risk of developing severe dengue (33). Ang1 is secreted 251 by pericytes and platelets to increase endothelial barrier function (27), while Ang2, produced 252 by endothelial cells and affecting pericyte coverage, is known to cause pericyte dropout in 253 diabetic retinopathy (27, 34) . It is tempting to speculate that one or more of these factors clinically associated with severe dengue might be indicative of a perturbation of pericyte 255 function by NS1 in vivo.
256
We propose a mechanism whereby, early during DENV infection, NS1 secreted into 257 patient serum induces well-described direct effects on endothelial cells causing local 258 permeability that allow NS1 to gain access to pericytes on the apical side of the endothelium 259 (Fig 4i-iii) . Subsequent effects of NS1 on pericytes cause a dysregulation of paracrine 260 signalling between pericytes and endothelial cells that leads to pronounced and potentially 261 life-threatening hyperpermeability that manifests during defervescence (Fig 4iv) . In patients 262 that recover, the integrity of the microvascular endothelium is restored as pericytes regain the 263 ability to support endothelial cell functions crucial to endothelial barrier formation and 264 maintenance (Fig 4v) .
265
Concentrations as high as 15,000 ng/ml of NS1 have been observed in the serum of 266 dengue patients, however patients with severe dengue most commonly have serum NS1 267 levels ranging between 10-1,000 ng/ml (12) (13) (14) . In our hands, NS1 affected the ability of 268 pericytes to support endothelial cell function in 3D microvascular co-cultures at concentrations 269 as low as 300 ng/ml ( Fig 2B) . To our knowledge, this is the lowest concentration at which 270 microvascular effects of NS1 have been demonstrated in vitro. Furthermore, in endothelial-271 pericyte co-cultures, the observed reduction in TEER upon treatment with 500 ng/ml of NS1 272 is dramatically larger compared to endothelial cells cultured alone ( Fig 1E) . We therefore 273 propose that modelling the essential role pericytes play in maintaining the microvascular 
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Statistical analysis
338
Values are reported as mean±SEM. Experiments were repeated with a minimum of 339 three independent biological replicates and three technical repeats within each replicate.
340
Statistical analyses were performed with GraphPad Prism 8 software (GraphPad Software 341 Inc, San Diego, CA USA). For Fig 1B, 1C, 1D , 3B and 4A, statistical analysis was by two-way 342 repeated-measures ANOVA with Dunnett correction for multiple comparisons. Fig 1E and 
